REVIEW article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1635123
This article is part of the Research TopicBacterial Metabolites: Redefining Strategies to Combat Antimicrobial ResistanceView all articles
Strategic Antagonism: How Lactobacillus plantarum Counters Staphylococcus aureus Pathogenicity
Provisionally accepted- 1Southeast Missouri State University, Cape Girardeau, United States
- 2Khulna University, Khulna, Bangladesh
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Staphylococcus aureus is a clinically significant pathogen known for its antibiotic resistance, immune evasion, and biofilm formation, making it a major contributor to persistent infections.Lactobacillus plantarum, a versatile probiotic bacterium, has emerged as a promising antagonist against S. aureus through multifaceted inhibitory mechanisms. This review synthesizes current evidence on the antagonistic interactions between L. plantarum and S. aureus, highlighting bacteriocin-mediated membrane disruption, quorum sensing interference, biofilm degradation, and metabolic competition. In addition, we explore how L. plantarum contributes to a less favorable inflammatory environment for S. aureus by modulating local immune responses at infection sites. Clinical relevance is explored across diverse anatomical sites such as the skin, vaginal tract, urinary system, and gastrointestinal tract, where L. plantarum demonstrates both direct and adjunctive therapeutic potential. We also consider environmental influences like pH and nutrient availability that modulate this antagonism. Together, the findings position L. plantarum as a compelling candidate for probiotic-based interventions against persistent and device-associated S. aureus infections.
Keywords: Staphylocccus aureus, Lactobacillus plantarum, Antagonism, Probiotics, antimicrobial, microbiota, metabolite, antibiotic resistance
Received: 26 May 2025; Accepted: 15 Jul 2025.
Copyright: © 2025 Bui, Bushra, Rattananon, Rimi, Lee, Tahmid, Tisha, Jisan, Das, Sneha, Pitts, Owasanoye, Khadka and Islam. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Shariful Islam, Southeast Missouri State University, Cape Girardeau, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.